Home › Funds › MATRIX ASSET ADVISORS INC/NY › ABT

MATRIX ASSET ADVISORS INC/NY position in ABT

ABBOTT LABORATORIES · Health Care

MATRIX ASSET ADVISORS INC/NY reported holding 52,805 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 0.43% of its reported portfolio and ranking #47 among its reported holdings. MATRIX ASSET ADVISORS INC/NY has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)52.80K sh
Reported value held$5.22M
Portfolio Weight0.43%
First reportedQ2 2026
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How MATRIX ASSET ADVISORS INC/NY's ABT position evolved

MATRIX ASSET ADVISORS INC/NY first disclosed a stake in ABT in Q2 2026 at 47,262 shares (US$4.3M). The position peaked in Q3 2026 at 52,805 shares, worth US$5.2M. Across 2 filings, MATRIX ASSET ADVISORS INC/NY increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 52,805 shares valued at US$5.2M — an increase of 5,543 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 47.26K $4.29M New
Q3 2026 52.80K $5.22M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has MATRIX ASSET ADVISORS INC/NY held ABT?

MATRIX ASSET ADVISORS INC/NY has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is MATRIX ASSET ADVISORS INC/NY's current position in ABT?

As of Q3 2026, MATRIX ASSET ADVISORS INC/NY holds 52.80K shares of ABT (ABBOTT LABORATORIES), valued at $5.22M, representing 0.43% of its reported portfolio and ranking #47.

Has MATRIX ASSET ADVISORS INC/NY been buying or selling ABT?

In the latest 13F filing (Q3 2026), MATRIX ASSET ADVISORS INC/NY increased its position in ABT. The position peaked in Q3 2026 at 52.80K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.